1. ATIM-15. SUSTAINED COMPLETE RADIOGRAPHIC RESPONSE AND PROLONGED SYSTEMIC IMMUNE ACTIVATION IN A PATIENT WITH MGMT UNMETHYLATED MIDLINE GLIOBLASTOMA RECEIVING CMV pp65-LAMP RNA-PULSED DENDRITIC CELL VACCINES. (11th November 2019) Authors: Rahman, Maryam; Ghiaseddin, Ashley; Yegorov, Oleg; Yang, Changlin; Dechkovskaia, Anjelika; Tran, David; Massini, Tara; Kresak, Jesse; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATIM-34. SINGLE-CELL RNA SEQUENCING REVEALS DYNAMIC IMMUNE RESPONSE CHANGES IN GLIOBLASTOMA PATIENT WITH DURABLE COMPLETE RESPONSE TO CMV PP65-LAMP RNA-PULSED DENDRITIC VACCINES. (11th November 2019) Authors: Yegorov, Oleg; Yang, Changlin; Rahman, Maryam; Ghiaseddin, Ashley; Dechkovskaia, Anjelika; Cleaver, Brian; Hodik, Marcia; Amdur, Robert; Massini, Tara; Kresak, Jesse; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTIM-29. CRUCIAL APPLICATION OF SINGLE CELL GENE EXPRESSION FOR MONITORING CHANGES IN GLIOBLASTOMA PATIENTS WITH SUSTAINED RADIOGRAPHIC RESPONSE TO CMV pp65-LAMP RNA-PULSED DENDRITIC CELL-BASED VACCINES. (9th November 2020) Authors: Yegorov, Oleg; Yang, Changlin; Dechkovskaia, Anjelika; Rahman, Maryam; Ghiaseddin, Ashley; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTIM-31. IMMUNOLOGIC MONITORING AFTER ADOPTIVE CELL THERAPY IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA USING IMMUNOGENOMICS APPROACH. (14th November 2022) Authors: Yegorov, Oleg; Yang, Changlin; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-44. PERSONALIZED IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA AND THEIR TREATMENT EFFICACY. (14th November 2022) Authors: Trivedi, Vrunda; Yang, Changlin; Fenton, Graeme; Yegorov, Oleg; Von Roemeling, Christina; Klippel, Kelena; Ogando-Rivas, Elizabeth; Castillo, Paul; Hoang-Minh, Lan; Dyson, Kyle; Moore, Ginger; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-47. PRECISION IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA USING CANCER IMMUNOGENOMICS AND SELECTIVE GENE ENRICHMENT STRATEGY. (9th November 2020) Authors: Trivedi, Vrunda; Yang, Changlin; Yegorov, Oleg; Dyson, Kyle; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-71. CHEMOTACTIC RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV) VIROTHERAPY IMPROVES LYMPHOCYTE RECRUITMENT IN GLIOBLASTOMA (GBM). (14th November 2022) Authors: von Roemeling, Christina; Klippel, Kelena; Trivedi, Vrunda; Yegorov, Oleg; Yang, Changlin; Hoang-Minh, Lan; Doonan, Bently; Ran, Yong; Golde, Todd; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IMMU-08. reMATCH PROTOCOL: PHASE II STUDY OF EX-VIVO EXPANDED AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (X-ALT) + TOTAL TUMOR RNA DC VACCINE (TT-RNA DC) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND PERIPHERAL BLOOD STEM CELL (PBSC) RESCUE OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) AND PBSC IN PATIENTS (PTS) WITH RECURRENT PNET (R-PNET). (4th December 2020) Authors: Gururangan, Sridharan; Hwang, Eugene; Dhall, Girish; Yegorov, Oleg; Governale, Lance; Blatt, Jason; Horn, Biljana; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. IMMU-13. MECHANISMS OF IMMUNOLOGICAL ESCAPE DURING ADOPTIVE CELLULAR THERAPY IN HIGH GRADE GLIOMA. (11th November 2019) Authors: Wildes, Tyler; Dyson, Kyle; Francis, Connor; Wummer, Brandon; Yang, Changlin; Yegorov, Oleg; Shin, David; Grippin, Adam; Divita, Bayli; Mitchell, Duane; Flores, Catherine Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IMMU-15. HIGH-RESOLUTION ANALYSIS OF THE T-CELL RECEPTOR REPERTOIRE AFTER ADOPTIVE CELLULAR THERAPY IN PEDIATRIC PATIENTS WITH CENTRAL PNETs (Re-MATCH TRIAL). Issue 2 (22nd June 2018) Authors: Yegorov, Oleg; Yegorova, Yanina; Dechkovskaia, Anjelika; Gururangan, Sridharan; Mitchell, Duane Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗